4-Fluoroethylphenidate

4-Fluoroethylphenidate
Identifiers
IUPAC name
  • Ethyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate
CAS Number
PubChem CID
Chemical and physical data
FormulaC15H20FNO2
Molar mass265.328 g·mol−1
3D model (JSmol)
SMILES
  • Fc1ccc(cc1)C(C(=O)OCC)C1CCCCN1
InChI
  • InChI=1S/C15H20FNO2/c1-2-19-15(18)14(13-5-3-4-10-17-13)11-6-8-12(16)9-7-11/h6-9,13-14,17H,2-5,10H2,1H3
  • Key:RKXQYWFDJDYSEN-UHFFFAOYSA-N

4-Fluoroethylphenidate (4F-EPH) is a recreational designer drug from the phenidate family, with stimulant effects. It was first identified in France in March 2016.[1] It has been used as a nootropic drug,[2] and was made illegal in the UK in 2017,[3] and in Sweden in 2018.[4]

See also

References

  1. ↑ "EMCDDA–Europol 2016 Annual Report on the implementation of Council Decision 2005/387/JHA" (PDF). Europol & European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
  2. ↑ Zaami S, Tagliabracci A, Berretta P, Busardò FP, Marinelli E (2019). "Use of Methylphenidate Analogues as Cognitive Enhancers: The Prelude to Cosmetic Neurology and an Ethical Issue". Frontiers in Psychiatry. 10: 1006. doi:10.3389/fpsyt.2019.01006. PMC 6989549. PMID 32038333.
  3. ↑ "The Misuse of Drugs Act 1971 (Amendment) Order 2017" (PDF). Government of the United Kingdom. 2017.
  4. ↑ "Ordinance amending the Ordinance (1999:58) banning certain products that are harmful to health. Notification Number: 2021/241/S". Swedish Code of Statutes.


This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.